Tabradol
NDC 43093-101
Product Information
Tabradol is a UNAPPROVED DRUG OTHER-approved product labeled by Fusion Pharmaceuticals Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 43093-101 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 43093-101?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P)
- CYCLOBENZAPRINE (UNII: 69O5WQQ5TI) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- GLYCERIN (UNII: PDC6A3C0OX)
- SORBITOL (UNII: 506T60A25R)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- DIMETHYL SULFONE (UNII: 9H4PO4Z4FT)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- CHERRY (UNII: BUC5I9595W)
- XANTHAN GUM (UNII: TTV12P4NEE)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
* Please review the full disclaimer at the bottom of this page.